Aino Health AB (publ) AINO.ST
AINO.ST
Aino Health AB (publ) QLIFE.ST
Qlife Holding AB (publ) EPIS-B.ST
Episurf Medical AB (publ) MODTX.ST
Modus Therapeutics Holding AB (publ) 2CUREX.ST
2cureX AB (publ) PROGEN.ST
Prostatype Genomics AB (publ) ORTI-B.ST
Ortivus AB (publ) SPERM.ST
Spermosens AB EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ) ODI.ST
ODI Pharma AB
Aino Health AB (publ) QLIFE.ST
Qlife Holding AB (publ) EPIS-B.ST
Episurf Medical AB (publ) MODTX.ST
Modus Therapeutics Holding AB (publ) 2CUREX.ST
2cureX AB (publ) PROGEN.ST
Prostatype Genomics AB (publ) ORTI-B.ST
Ortivus AB (publ) SPERM.ST
Spermosens AB EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ) ODI.ST
ODI Pharma AB
Performance
| Periode | AINO.ST | QLIFE.ST | EPIS-B.ST | MODTX.ST | 2CUREX.ST | PROGEN.ST | ORTI-B.ST | SPERM.ST | EXPRS2.ST | ODI.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 3.52 % | 3.37 % | -59.52 % | -67.19 % | 152.53 % | -66.67 % | -23.47 % | -24.44 % | -4.02 % | -40.19 % |
| YTD | -14.17 % | 3.37 % | -65.42 % | -76.14 % | 273.75 % | -93.55 % | -22.41 % | -48.48 % | -23.69 % | -48.80 % |
| 1Y | 71.67 % | -11.16 % | -66.84 % | -70.42 % | 169.37 % | -94.89 % | -30.12 % | -68.81 % | -46.12 % | -59.75 % |
| 3Y | -11.84 % | -99.98 % | -97.38 % | -79.90 % | -82.97 % | -99.90 % | -78.03 % | -99.82 % | -95.95 % | -74.50 % |
| 5Y | -77.77 % | -99.99 % | -97.79 % | -92.00 % | -90.32 % | -99.97 % | -78.89 % | -99.91 % | -96.05 % | -73.44 % |
| 10Y | -98.28 % | -99.99 % | -99.57 % | -92.00 % | -80.35 % | -99.97 % | -66.60 % | -99.91 % | -91.20 % | -86.89 % |
| From the beginning | -98.28 % | -99.99 % | -99.30 % | -92.00 % | -80.35 % | -99.97 % | -96.86 % | -99.91 % | -91.20 % | -86.89 % |